HORIZON PHARMA PLC's ticker is and the CUSIP is G4617B905. A total of 4 filers reported holding HORIZON PHARMA PLC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,377,000 | +219.5% | 521 | +135.7% | 0.00% | +300.0% |
| Q4 2018 | $431,000 | -27.3% | 221 | -27.1% | 0.00% | -50.0% |
| Q3 2018 | $593,000 | +139.1% | 303 | +102.0% | 0.00% | +100.0% |
| Q2 2018 | $248,000 | +1081.0% | 150 | -9.6% | 0.00% | 0.0% |
| Q1 2018 | $21,000 | -61.1% | 166 | -68.1% | 0.00% | -50.0% |
| Q4 2017 | $54,000 | +170.0% | 521 | +27.7% | 0.00% | +100.0% |
| Q3 2017 | $20,000 | -9.1% | 408 | +2.8% | 0.00% | 0.0% |
| Q2 2017 | $22,000 | -79.8% | 397 | -75.5% | 0.00% | -80.0% |
| Q1 2017 | $109,000 | -40.1% | 1,619 | -65.9% | 0.01% | -54.5% |
| Q4 2016 | $182,000 | +49.2% | 4,750 | +1173.5% | 0.01% | +37.5% |
| Q3 2016 | $122,000 | +154.2% | 373 | -28.8% | 0.01% | +166.7% |
| Q2 2016 | $48,000 | -42.2% | 524 | +34.4% | 0.00% | -57.1% |
| Q1 2016 | $83,000 | -45.4% | 390 | +21.1% | 0.01% | -41.7% |
| Q4 2015 | $152,000 | +26.7% | 322 | -71.5% | 0.01% | +33.3% |
| Q3 2015 | $120,000 | -22.1% | 1,129 | +985.6% | 0.01% | -30.8% |
| Q2 2015 | $154,000 | -74.0% | 104 | -73.3% | 0.01% | -81.2% |
| Q1 2015 | $592,000 | – | 390 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 169,000 | $5,871,000 | 0.08% |
| SIMPLEX TRADING, LLC | 104 | $154,000 | 0.01% |
| Citadel Advisors | 105,600 | $3,669,000 | 0.00% |